Migdal Insurance & Financial Holdings Ltd. Sangamo Therapeutics, Inc Call Options Transaction History
Migdal Insurance & Financial Holdings Ltd.
- $6.97 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SGMO
# of Institutions
141Shares Held
60.4MCall Options Held
1.46MPut Options Held
1.84M-
Vanguard Group Inc Valley Forge, PA9.37MShares$8.16 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT9.23MShares$8.03 Million0.05% of portfolio
-
State Street Corp Boston, MA5.02MShares$4.37 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$4.09 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.08MShares$2.68 Million0.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $136M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...